News

As soon as you share your screen, it's like everyone's eye zooms in on the unsavory open tab that seems to be flashing neon ...
Shari Ouellette, chair of the Regional School Unit 73 board of directors invited Maine Parents' Rights in Education director Allen Sarvinas to speak to the board at the May 22 meeting in Jay.
Dosing cohort 3 of Phase 1 trial of CTIM-76, a Claudin 6 x CD3 T cell engager. Expect to share initial data in the first half of 2026. PHILADELPHIA, June 02, 2025 (GLOBE NEWSWIRE) -- Context ...
Oral Presentation (1506): A technology-enabled clinical trial program’s impact on patient screening and trial enrollment in 2024 Date/Time: Monday, June 2 from 3:00 PM–6:00 PM CDT ...
--BeyondSpring Inc., a clinical-stage global biopharmaceutical company focused on developing cancer therapies, today announces that it will have a poster presentation on 303 Study, the ...
FLORHAM PARK, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing cancer ...
Company management line icons set Line icons set with flat design elements of business people management, company growth presentation, seminar training, human resources and retirement. Modern vector ...
WASHINGTON, May 27, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at the American Society of Clinical Psychopharmacology (ASCP) Annual ...
WASHINGTON, May 27, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, ...